|
FAM175B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.652000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.684500E-02 |
| Normal-vs-Stage2 |
3.250400E-01 |
| Normal-vs-Stage3 |
9.342000E-02 |
| Normal-vs-Stage4 |
5.028000E-01 |
| Stage1-vs-Stage2 |
9.324400E-01 |
| Stage1-vs-Stage3 |
6.119200E-01 |
| Stage1-vs-Stage4 |
9.819600E-01 |
| Stage2-vs-Stage3 |
6.212000E-01 |
| Stage2-vs-Stage4 |
9.690200E-01 |
| Stage3-vs-Stage4 |
7.344800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.718200E-02 |
| Normal-vs-AfricanAmerican |
7.122200E-01 |
| Normal-vs-Asian |
4.415400E-01 |
| Caucasian-vs-AfricanAmerican |
2.680400E-01 |
| Caucasian-vs-Asian |
6.835600E-01 |
| AfricanAmerican-vs-Asian |
4.568800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.283780E-02 |
| Normal-vs-Female |
8.433200E-01 |
| Male-vs-Female |
5.234200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.953610E-02 |
| Normal-vs-Extreme_Weight |
7.118600E-03 |
| Normal-vs-Obese |
5.444600E-01 |
| Normal-vs-Extreme_Obese |
2.719000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.841600E-01 |
| Normal_Weight-vs-Obese |
1.024820E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.562800E-01 |
| Extreme_Weight-vs-Obese |
9.479600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.679200E-01 |
| Obese-vs-Extreme_Obese |
4.272800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.102000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.364400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.379100E-03 |
| Normal-vs-Age(81-100Yrs) |
2.242300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.925200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.163580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.588000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.402300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.704100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.188000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.517400E-01 |
| Normal-VS-Type2 PRCC |
3.571500E-04 |
| Normal-VS-KIRP CIMP |
6.083800E-01 |
| Normal-VS-Unclassified PRCC |
9.358200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.900700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.474800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.375200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.368100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.923800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.624200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.74999999999726E-05 |
| Normal-vs-N1 |
8.906000E-01 |
| Normal-vs-N2 |
8.428500E-04 |
| N0-vs-N1 |
8.660300E-03 |
| N0-vs-N2 |
3.993800E-01 |
| N1-vs-N2 |
9.882300E-02 |
|
|
